文献速递胸部CT

常规CT特征预测晚期肺腺癌EGFR突变

Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
PubMed 文献 · Eur J Radiol · 2019-01-07

本回顾性研究纳入2017年1月至8月确诊的201例晚期肺腺癌患者,评估常规CT特征(原发灶、转移灶、淋巴结、肺气肿)预测EGFR突变的能力。多因素分析显示EGFR突变与较小淋巴结、较低的原发灶深分叶比例、淋巴结部分融合及无肺气肿显著相关,逻辑回归模型预测EGFR突变的AUC为0.898。

要点

  • EGFR突变与较小淋巴结、较低原发灶深分叶比例、淋巴结部分融合及无肺气肿显著相关。
  • 逻辑回归模型预测EGFR突变的AUC为0.898。
  • EGFR突变组的CT表现相对低恶性度、侵袭性较低。

核心结论

  • 常规CT特征(肺气肿、原发灶分叶程度、淋巴结大小和状态)有助于预测晚期肺腺癌EGFR突变的存在与否;EGFR突变组的CT表现相对低恶性度、侵袭性较低。

研究设计与样本

  • 回顾性研究,纳入201例晚期肺腺癌患者,均接受胸部CT和EGFR突变检测,评估定性、定量CT特征及临床特征。

关键影像表现/征象

  • EGFR突变与较小淋巴结、较低的原发灶深分叶比例、淋巴结部分融合及无肺气肿显著相关。
  • EGFR突变组的CT表现相对低恶性度、侵袭性较低,与野生型EGFR组相比。

诊断标准与关键数值

  • 逻辑回归模型预测EGFR突变的AUC为0.898。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study assessed the ability of conventional computed tomography (CT) features (including primary tumors, metastatic lesions, lymph nodes, and emphysema) to predict epidermal growth factor receptor (EGFR) mutations in advanced pulmonary adenocarcinoma.

METHODS: Patients who were diagnosed with advanced pulmonary adenocarcinoma between January 2017 and August 2017 and had undergone a chest CT and EGFR mutation testing were enrolled in this retrospective study. Qualitative and quantitative CT-features and clinical characteristics evaluated in this study included: primary tumor location, size, and morphology (including degree of lobulation, density, calcification, cavitation, vacuole sign, and air bronchogram), size and distribution of lung and pleural metastatic nodules, size and status of hilar and mediastinal lymph nodes, emphysema, organs with distant metastasis, and patient age, sex, and smoking history.

RESULTS: Of 201 patients, 107 (53.23%) were EGFR-mutation positive. The multivariate logistic regression indicated that EGFR mutations were significantly associated with smaller lymph nodes, a lower percentage of deep lobulation of the primary tumor and partial fusion of lymph nodes, and absence of emphysema. The area under the curve of logistic regression model for predicting EGFR mutations was 0.898.

CONCLUSIONS: Conventional CT-features, including emphysema, degree of primary tumor lobulation, and lymph node size and status, help to predict the presence or absence of EGFR mutations in advanced pulmonary adenocarcinoma. Additionally, these same CT-features demonstrated that the CT manifestations of the EGFR mutant group were of relatively lower malignancy and less invasive as compared to the wild-type EGFR group.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Yang Y, Ma L, et al. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma. Eur J Radiol. 2019. PMID: 30777218. doi:10.1016/j.ejrad.2019.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。